Literature DB >> 28067434

Pioglitazone and bladder cancer: FDA's assessment.

Christian Hampp1, Jennifer Pippins2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28067434     DOI: 10.1002/pds.4154

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  11 in total

Review 1.  Therapeutic pipeline in nonalcoholic steatohepatitis.

Authors:  Raj Vuppalanchi; Mazen Noureddin; Naim Alkhouri; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-10       Impact factor: 46.802

2.  Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.

Authors:  Elizabeth M Garry; John B Buse; Jennifer L Lund; Virginia Pate; Til Stürmer
Journal:  Diabetes Obes Metab       Date:  2017-08-08       Impact factor: 6.577

3.  Effects of thiazolidinedione in patients with active bladder cancer.

Authors:  Roger Li; Michael J Metcalfe; James E Ferguson; Sharada Mokkapati; Graciela M Nogueras González; Colin P Dinney; Neema Navai; David J McConkey; Sunil K Sahai; Ashish M Kamat
Journal:  BJU Int       Date:  2017-09-23       Impact factor: 5.588

4.  Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice.

Authors:  G Kim; Y-H Lee; M R Yun; J-Y Lee; E G Shin; B-W Lee; E S Kang; B-S Cha
Journal:  Int J Obes (Lond)       Date:  2017-09-12       Impact factor: 5.095

5.  Implications of Removing Rosiglitazone's Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among Patients with Type 2 Diabetes.

Authors:  Ryan P Hickson; Ashley L Cole; Stacie B Dusetzina
Journal:  J Manag Care Spec Pharm       Date:  2019-01

Review 6.  Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis.

Authors:  Yifeng Xu; Yanxiang Wu; Qin Huang
Journal:  Arch Gynecol Obstet       Date:  2017-08-02       Impact factor: 2.344

Review 7.  The Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARG) in Adipogenesis: Applying Knowledge from the Fish Aquaculture Industry to Biomedical Research.

Authors:  Rebecca Wafer; Panna Tandon; James E N Minchin
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-22       Impact factor: 5.555

Review 8.  Novel Anti-fibrotic Therapies.

Authors:  Benita L McVicker; Robert G Bennett
Journal:  Front Pharmacol       Date:  2017-05-31       Impact factor: 5.810

9.  Peroxisome proliferator-activated receptor gamma agonist as a novel treatment for interstitial cystitis: A rat model.

Authors:  Amandeep Mahal; Nichole Young-Lin; Amy Dobberfuhl; Jaclyn Estes; Craig Vance Comiter
Journal:  Investig Clin Urol       Date:  2018-06-15

10.  Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects.

Authors:  Muhammad Shahid; Minhyung Kim; Austin Yeon; Peng Jin; Woong-Ki Kim; Sungyong You; Jayoung Kim
Journal:  Int Neurourol J       Date:  2020-03-31       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.